Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02536482
Other study ID # U1111-1173-4156
Secondary ID
Status Completed
Phase Phase 2
First received August 20, 2015
Last updated August 28, 2015
Start date August 2013
Est. completion date June 2015

Study information

Verified date August 2015
Source Edetec Indústria Alimentícia S.A.
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

It is a study to assess the tolerance to a new commercially available infant formula in children affected by Cow`s Milk Allergy.


Description:

In the present study, the children will be followed-up during the treatment with the new formula for Cow`s Milk Allergy. They will have monthly doctor`s appointment, when the weight, height and symptoms will be evaluated, by a questionnaire and a physical examination.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date June 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group N/A to 5 Years
Eligibility Inclusion Criteria:

- Children with cow`s milk allergy

Exclusion Criteria:

- Children without cow`s milk allergy

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Dietary Supplement:
Amix
Treat the children with cow`s milk allergy for 5 months.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Edetec Indústria Alimentícia S.A. Faculdade de Ciências Médicas de Minas Gerais, Federal University of Minas Gerais

Outcome

Type Measure Description Time frame Safety issue
Primary Study to assess the allergic symptoms, using a questionnaire. The allergic symptoms were assessed every month, by using a questionnaire. The parents, during the medical appointment, answered "yes" or "no" according to the presented symptoms: cutaneous (atopic dermatitis and urticaria), gastrointestinal (vomiting, diarrhea constipation and bloody stools ) and respiratory. At the end of the study the children were evaluated if they tolerated the formula, it was observed by the symptoms remission. 5 months Yes
Secondary Weight assessment, using a digital infant scale Every medical appointment the doctor measured the weight, by using a digital infant scale. The values were plotted in the software WHO Anthro. A curve weight/age was obtained and the children`s weight were compared to the standard population`s weight, by the z-score. 5 months Yes
Secondary Height assessment, using an infantometer Every medical appointment the doctor measured the height by using a digital infant scale. The values were plotted in the software Anthro. A curve height/age was obtained and the children`s height were compared to the standard population`s height, by the z-score. 5 months Yes
Secondary Head circumference, using an infant tape measure Every medical appointment the doctor measured the head circumference by using a infant tape measure. The values were plotted in the software Anthro. A curve head circumference/age was obtained and the children`s head circumference were compared to the standard population`s head circumference, by the z-score. 5 months Yes